Elsevier

Indian Journal of Medical Microbiology

Volume 21, Issue 3, July–September 2003, Pages 152-160
Indian Journal of Medical Microbiology

Review Article
SEVERE ACUTE RESPIRATORY SYNDROME

https://doi.org/10.1016/S0255-0857(21)03064-4Get rights and content
Under a Creative Commons license
open access

Abstract

Severe acute respiratory syndrome (SARS) is a form of atypical pneumonia that apparently originated in Guangdong Province of the People’s Republic of China in late 2002. This first came to the world’s attention in late February 2003, and has since spread worldwide. As of June 23rd 2003, the disease had been reported from 32 countries or regions globally, affecting 8459 people; 805 individuals (9.5 % of the total affected) have died of the disease. A novel coronavirus, the SARS-associated coronavirus (SARS-CoV) has been found in various specimens taken from patients with SARS. Although there has been rapid development of tests to detect SARS Co-V, these tests presently have certain limitations. Definitions of suspected, confirmed and probable cases have been formulated. Measures currently used for the management of patients with SARS include isolation, ribavirin, corticosteroid therapy and mechanical ventilation. Unfortunately, almost 10 % of affected patients succumb to their illness, underlying the need for developing more effective therapy. It remains to be seen how long it will take to bring this epidemic under control.

Key words:

SARS
Coronavirus
epidemic
China

Cited by (0)